Why ISO 81060-2 Matters for Accurate Blood Pressure Monitoring   Non-invasive blood pressure devices must demonstrate dependable performance before developers can advance toward FDA or CE mark submissions. ISO 81060-2  “Non-invasive sphygmomanometers — Part 2: Clinical investigation of intermittent automated measurement type ” sets a clear bar for clinical validation—defining study methods, reference comparisons, subject distribution, cuff/arm-size coverage, and prespecified

How PRL Ensures Data Integrity in Physiological Monitoring Research   For CTOs and technical leaders in MedTech, data integrity is not a paperwork detail—it is the backbone of regulator-ready evidence. Whether your device requires pulse oximetry testing during controlled desaturation in a hypoxia lab, multi-parameter wearables validation, or multi-site clinical research studies, every data point must be defensible. ALCOA+ provides the industry-standard framework for achieving

At Parameters Research Laboratory (PRL) , we specialize in providing regulatory-grade validation for blood pressure monitoring devices, including both traditional cuff-based devices and emerging cuffless wearables. As a dedicated blood pressure validation testing lab , we deliver the scientific rigor and regulatory alignment developers need to succeed in FDA and CE mark submissions.    Why Blood Pressure Validation Matters   Accuracy in blood pressure monitoring is critical

Blood Pressure Monitoring: A Clinical Cornerstone   Blood pressure measurement is one of the most common clinical assessments, shaping decisions in nearly every healthcare setting. However, not all blood pressure monitors provide the accuracy needed for safe clinical use. FDA-approved devices  stand apart by meeting strict accuracy standards backed by international validation protocols  and clinical research studies .  In the United States, most blood pressure monitors aren’t